Japanese pharma Otsuka is acquiring Mindset Pharma for $59 million, adding a suite of preclinical psychedelics. The larger company is looking to build on its portfolio of Lundbeck-partnered antipsychotics that each raked in hundreds of millions of dollars last quarter.

Some six months after Sanofi's former R&D chief John Reed announced his jump to Johnson & Johnson, the pharma has found his replacement, naming Houman Ashrafian for the job.

Fierce Biotech's M&A Tracker, your one-stop shop for dealmaking in the biopharma universe.

A team co-led by Carl June, M.D., has created CAR-Ts that target the antigen CD45, a protein found on the surface of nearly all blood cells. They knocked out leukemia cells in mice in just three weeks.

Friday, the U.S. Federal Trade Commission (FTC) said it reached a proposed consent order with Amgen to address “the potential competitive harm” that could result from the merger deal. Now, Amgen is free to go forward with its $28 billion buyout.

In a flurry of Aug. 31 notices from the FDA, the number of Class I recalls plaguing Getinge’s Cardiosave intra-aortic balloon pumps this year has doubled.

Organizations signed a letter pledging support for a CMS-backed transitional coverage for emergency technologies pathway, which they say could improve patient care, prevent hospitalizations and reduce costs.

It was a year ago this month that President Joe Biden signed the Inflation Reduction Act. While the landmark bill introduces several pricing measures, Democrats on Capitol Hill are still pursuing ways to rein in the pharma industry. They are pressing insulin manufacturers on their plans to cut prices. They also are asking the FDA to adjust its management of the patent system to bolster competition.